Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.

Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.

It has been found that preoperative plasma IGFBP-2 levels correlate with prognosis in glioma patients. The prognostic value of plasma IGFBP-2 after postoperative combined radiotherapy and chemotherapy in glioma patients is unknown. Plasma IGFBP-2 levels in 83 glioblastoma patients after postoperativ...

Full description

Bibliographic Details
Main Authors:	Sheng Han, Lingxuan Meng, Shuai Han, Yunjie Wang, Anhua Wu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3972244?pdf=render

Similar Items

NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells.
by: Xinxin Tie, et al.
Published: (2013-01-01)

PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells.
by: Sheng Han, et al.
Published: (2013-01-01)

Influence of GSTP-1 Genetic Variation on Prognosis of Postoperative Glioblastoma Patients Received Temozolomide Combined with Radiotherapy Regimens
by: ZHAO Ke, et al.
Published: (2019-11-01)

<it>In vitro </it>evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells
by: Combs Stephanie E, et al.
Published: (2012-01-01)

TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas.
by: Chen Chen, et al.
Published: (2014-01-01)

Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review
by: AmirAhmad Arabzadeh, et al.
Published: (2021-07-01)

Regulation of Expression of Immune Checkpoints in Glioblastoma Multiforme by Chemotherapy and Radiotherapy
by: Yii Ching Ng, et al.
Published: (2019)

Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
by: Xue Song, et al.
Published: (2018-09-01)

Radiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysis.
by: An-an Yin, et al.
Published: (2013-01-01)

Combination of Haemoglobin and Prognostic Nutritional Index Predicts the Prognosis of Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
by: Wang B, et al.
Published: (2020-09-01)

Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
by: Evrim Metcalfe, et al.
Published: (2016-08-01)

Short Course Hypofractionated Radiotherapy versus Conventional Radiotherapy for Poor Prognosis Glioblastoma Multiforme: A Randomised Controlled Trial
by: SUNIL CHOUDHARY, et al.
Published: (2019-03-01)

Adaptive hypofractionated radiotherapy combined with chemotherapy and anti-angiogenic therapy for residual and recurrent glioblastoma after surgery: A case report
by: Yuchao Ma, et al.
Published: (2020-01-01)

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma
by: Chen Zhu, et al.
Published: (2019-09-01)

The influence of radiotherapy on the immune status of glioblastoma
by: Meng⁃lin NIE, et al.
Published: (2020-02-01)

Simulation predicts IGFBP2-HIF1α interaction drives glioblastoma growth.
by: Ka Wai Lin, et al.
Published: (2015-04-01)

Advances in Radiotherapy for Glioblastoma
by: Justin Mann, et al.
Published: (2018-01-01)

Assessment of Functional Status and Quality of Life of Elderly Patients Undergoing Radiotherapy and Radiotherapy Combined with Chemotherapy – A Cross-Sectional Study
by: Muszalik M, et al.
Published: (2021-01-01)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
by: Makoto Ohno, et al.
Published: (2019-11-01)

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report
by: J. Biau, et al.
Published: (2017-12-01)

Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience
by: Christoph Straube, et al.
Published: (2017-04-01)

Intensity-Modulated Radiotherapy with Concurrent Chemotherapy for Elder Cervical Cancers: A Comparison of Clinical Outcomes with Conventional Radiotherapy
by: Meng-Hao Wu, et al.
Published: (2016-09-01)

Efficacy of combined radiotherapy and chemotherapy versus radiotherapy for oral squamous cell carcinoma
by: Jaime Irisarri Arévalo, et al.

Efficacy of combined radiotherapy and chemotherapy versus radiotherapy for oral squamous cell carcinoma
by: Patricio Fabian Oliva Mella, et al.
Published: (2015-06-01)

Combined radiotherapy and chemotherapy for high-grade brain tumours
by: Barazzuol, Lara
Published: (2012)

IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells
by: Chengyuan Dong, et al.
Published: (2020-02-01)

IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer.
by: Meng Xue, et al.
Published: (2013-01-01)

Effect of Postoperative Chemotherapy on Prognosis of Postoperative Lymph Node-positive Thoracic Esophageal Squamous Cell Carcinoma Patients
by: SHEN Wenbin, et al.
Published: (2018-10-01)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
by: Xiaojie Feng, et al.
Published: (2020-12-01)

HYPOFRACTIONATED RADIOTHERAPY IN GLIOBLASTOMA MULTIFORME
by: Sadaf Usman, et al.
Published: (2015-11-01)

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
by: Ducray François, et al.
Published: (2010-09-01)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
by: Hang Ji, et al.
Published: (2021-09-01)

Delayed postoperative radiotherapy increases the incidence of radiographic local tumor progression before radiotherapy and leads to poor prognosis in spinal metastases
by: Yining Gong, et al.
Published: (2021-01-01)

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience
by: Liangzhi Zhong, et al.
Published: (2019-06-01)

IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
by: Yunmian Liu, et al.
Published: (2019-01-01)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
by: Ann H. Rosendahl, et al.
Published: (2021-03-01)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
by: Yanan Wu, et al.
Published: (2017-05-01)

Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
by: Anjani Kumar Jha, et al.
Published: (2019-03-01)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
by: Li Jin, et al.
Published: (2020-05-01)

The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
by: Liang Peng, et al.
Published: (2019-01-01)